Product Code: PM4033
The global drug discount card market size is expected to reach USD 28.68 million by 2032, according to a new study by Polaris Market Research. The report "Drug Discount Card Market Share, Size, Trends, Industry Analysis Report, By Type (Generic Card, Branded Card); By Sales Channel; By Application; By Region; Segment Forecast, 2023- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Drug discount cards extend invaluable savings on prescription medications for those lacking prescription drug coverage. Issued by private entities or non-profits, these cards offer users substantial discounts ranging from 10-25%. Their key benefits encompass notable cost reductions, straightforward accessibility, and extensive coverage of both drugs and pharmacies.
The significant population of uninsured and underinsured individuals in the US, burdened by exorbitant prescription costs, stands as a pivotal driver for the drug discount card market. In 2021, data revealed that over 31 million Americans were without insurance coverage. Moreover, millions more grapple with underinsurance, facing high deductibles and copays. Absent sufficient prescription drug coverage, retail medication prices become overwhelmingly steep. Drug discount cards step in to alleviate this burden, rendering necessary medications more affordable through substantial discounts. For the uninsured, discount cards can curtail out-of-pocket expenses by an impressive 60%. This substantial target demographic heavily relies on discount cards to mitigate their prescription expenses, further propelling market growth.
Emerging markets in the Asia Pacific, Latin America, and Africa present substantial growth prospects for drug discount card companies. These regions often have significant underinsured and uninsured populations, largely due to comparatively lower healthcare infrastructure and spending compared to developed counterparts. The expenditure on medications out-of-pocket is notably high in these markets.
In response, local startups in these emerging markets are introducing inventive discount card programs and e-health platforms finely tailored to their unique healthcare landscapes. For example, in Africa, a mobile health application offers discounted prescriptions and telehealth services, while in India, a platform provides reduced-cost lab tests and medicines.
This burgeoning opportunity also extends to global discount card players, who can seize the potential for expansion by forging strategic partnerships with local entities in these high-growth emerging markets.
Drug Discount Card Market Report Highlights
- Generic card segment is expected to grow at a highest CAGR during the projected period, on account of cost-effectiveness
- Offline segment accounted for largest market share in 2022, which is mainly driven by more tangibility
- Essential medicines segment held the significant market revenue share in 2022, mainly due to ease in accessibility, and lower prices of medicines
- North America region dominated the market with majority share in 2022, owing to escalating healthcare costs, and government support
- The global key market players include: Blink Health, Coast2Coast Rx, GoodRx, HealthWarehouse.com, Inc., Inside Rx (Express Scripts)
Polaris Market Research has segmented the drug discount card market report based on type, sales channel, application, and region:
Drug Discount Card, Type Outlook (Revenue - USD Million, 2019 - 2032)
- Generic Card
- Branded Card
Drug Discount Card, Sales Channel Outlook (Revenue - USD Million, 2019 - 2032)
Drug Discount Card, Application Outlook (Revenue - USD Million, 2019 - 2032)
- Essential Medicines
- Rare Diseases
- Chronic Diseases
- Others
Drug Discount Card, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Drug Discount Card Market Insights
- 4.1. Drug Discount Card Market - Application Snapshot
- 4.2. Drug Discount Card Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing healthcare expenditure
- 4.2.1.2. Increasing Prescription Drug Prices
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Lack of Awareness
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Drug Discount Card Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Drug Discount Card Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 5.3. Generic Card
- 5.3.1. Global Drug Discount Card Market, by Generic Card, by Region, 2019-2032 (USD Million)
- 5.4. Branded Card
- 5.4.1. Global Drug Discount Card Market, by Branded Card, by Region, 2019-2032 (USD Million)
6. Global Drug Discount Card Market, by Sales Channel
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 6.3. Online
- 6.3.1. Global Drug Discount Card Market, by Online, by Region, 2019-2032 (USD Million)
- 6.4. Offline
- 6.4.1. Global Drug Discount Card Market, by Offline, by Region, 2019-2032 (USD Million)
7. Global Drug Discount Card Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 7.3. Essential Medicines
- 7.3.1. Global Drug Discount Card Market, by Essential Medicines, By Region, 2019-2032 (USD Million)
- 7.4. Rare Diseases
- 7.4.1. Global Drug Discount Card Market, by Rare Diseases, By Region, 2019-2032 (USD Million)
- 7.5. Chronic Diseases
- 7.5.1. Global Drug Discount Card Market, by Chronic Diseases, By Region, 2019-2032 (USD Million)
- 7.6. Others
- 7.6.1. Global Drug Discount Card Market, by Others, By Region, 2019-2032 (USD Million)
8. Global Drug Discount Card Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Drug Discount Card Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. Drug Discount Card Market - North America
- 8.3.1. North America: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.3.2. North America: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.3.3. North America: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.3.4. Drug Discount Card Market - U.S.
- 8.3.4.1. U.S.: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.3.5. Drug Discount Card Market - Canada
- 8.3.5.1. Canada: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.3.5.3. Canada: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.4. Drug Discount Card Market - Europe
- 8.4.1. Europe: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.4.2. Europe.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.4.3. Europe: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.4.4. Drug Discount Card Market - UK
- 8.4.4.1. UK: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.4.4.2. UK.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.4.4.3. UK: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.4.5. Drug Discount Card Market - France
- 8.4.5.1. France: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.4.5.2. France.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.4.5.3. France: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.4.6. Drug Discount Card Market - Germany
- 8.4.6.1. Germany: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.4.6.3. Germany: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.4.7. Drug Discount Card Market - Italy
- 8.4.7.1. Italy: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.4.7.3. Italy: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.4.8. Drug Discount Card Market - Spain
- 8.4.8.1. Spain: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.4.8.3. Spain: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.4.9. Drug Discount Card Market - Netherlands
- 8.4.9.1. Netherlands: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.4.10. Drug Discount Card Market - Russia
- 8.4.10.1. Russia: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.4.10.3. Russia: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.5. Drug Discount Card Market - Asia Pacific
- 8.5.1. Asia Pacific: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.5.4. Drug Discount Card Market - China
- 8.5.4.1. China: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.5.4.2. China.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.5.4.3. China: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.5.5. Drug Discount Card Market - India
- 8.5.5.1. India: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.5.5.2. India.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.5.5.3. India: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.5.6. Drug Discount Card Market - Malaysia
- 8.5.6.1. Malaysia: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.5.7. Drug Discount Card Market - Japan
- 8.5.7.1. Japan: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.5.7.3. Japan: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.5.8. Drug Discount Card Market - Indonesia
- 8.5.8.1. Indonesia: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.5.9. Drug Discount Card Market - South Korea
- 8.5.9.1. South Korea: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.6. Drug Discount Card Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.6.4. Drug Discount Card Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.6.5. Drug Discount Card Market - UAE
- 8.6.5.1. UAE: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.6.5.3. UAE: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.6.6. Drug Discount Card Market - Israel
- 8.6.6.1. Israel: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.6.6.3. Israel: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.6.7. Drug Discount Card Market - South Africa
- 8.6.7.1. South Africa: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.7. Drug Discount Card Market - Latin America
- 8.7.1. Latin America: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.7.3. Latin America: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.7.4. Drug Discount Card Market - Mexico
- 8.7.4.1. Mexico: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.7.5. Drug Discount Card Market - Brazil
- 8.7.5.1. Brazil: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
- 8.7.6. Drug Discount Card Market - Argentina
- 8.7.6.1. Argentina: Drug Discount Card Market, by Type, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: Drug Discount Card Market, by Application, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: Drug Discount Card Market, by Sales Channel, 2019-2032 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. AARP Prescription Discounts (UnitedHealth Group)
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Blink Health
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Coast2Coast Rx
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. GoodRx
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. HealthWarehouse.com, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Inside Rx (Express Scripts)
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Kroger Rx Savings Club
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. OptumRx (UnitedHealth Group)
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Pharmacy Savings Powered
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. SingleCare Services, LLC
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. ScriptSave WellRx
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Simple Savings Card
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. United Networks of America
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. USA Rx
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Watertree Health
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development